Methods and pharmaceutical compositions employing S(+)-desmethylselegiline to treat neoplastic diseases or conditions

摘要

The application is directed to the treatment of neoplastic diseases or conditions by administering R(-) desmethylselegiline, S(+) desmethylselegiline, or a combination of the two. Neoplastic diseases and conditions responsive to R(-) desmethylselegiline and/or S(+) desmethylselegiline include both malignant and benign neoplasms.